Birmingham University to develop lollipop for mouth cancer detection

疫苗
Birmingham University to develop lollipop for mouth cancer detection
Preview
来源: Pharmaceutical Technology
Researchers will create a prototype flavoured “lollipop” from a smart hydrogel. Credit: University of Birmingham.
The University of Birmingham in the UK has secured £350,000 ($440,958) to develop a flavoured lollipop for the early detection of mouth cancer.
The project, by the university’s biosensors associate professor Dr Ruchi Gupta and her team, is backed by a grant from Cancer Research UKCancer Research UK and the Engineering and Physical Sciences Research Council.
Researchers will receive the funds up to 2026 to develop a prototype from a smart hydrogel.
Smart hydrogel is composed of 99% water and 1% polymer and can absorb significant quantities of water. It traps larger molecules such as proteins, which can then be released and analysed for early signs of mouth cancer.
Patients will transfer saliva into the hydrogel by sucking on the lollipop. Scientists can then expose the hydrogel to UV light to release the captured proteins and analyse them for indicators of mouth cancer.
See Also:
Cancer Research UK and CRIS fund lung cancer vaccine research
Birmingham University to develop lollipop for mouth cancer detection
Preview
来源: Pharmaceutical Technology
Pharmaceutical consulting companies, pharmaceutical training and other development services
Birmingham University to develop lollipop for mouth cancer detection
Preview
来源: Pharmaceutical Technology
Gupta stated: “Smart hydrogels have really exciting potential for diagnosing mouth cancer. They can be easily moulded into shapes as a solid to ‘catch’ proteins in saliva.
“We’re really excited to start the next phase of this project. We’re hoping that we can be the first to make a device which is much kinder for diagnosing mouth cancer for patients and easier for GPs to use.”
This innovative approach could significantly improve the current diagnostic process for mouth cancer, which often involves invasive procedures such as endoscopy and biopsies.
With 12,400 individuals diagnosed with head and neck cancers annually in the UK, this research could lead to a less invasive, quicker and more patient-friendly method for early detection.
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。